Alpine Immune Sciences, Inc. (ALPN) Moves 9.5% Higher: Will This Strength Last?Zacks Investment Research • 05/20/21
Alpine Immune Sciences To Host Investor Event at 2021 ASCO Virtual Annual MeetingBusiness Wire • 05/19/21
Alpine Immune Sciences Announces Oral Presentation at the 2021 EULAR Virtual MeetingBusiness Wire • 05/18/21
Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/13/21
Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2021 Financial ResultsBusiness Wire • 05/13/21
Alpine Immune Sciences to Present ALPN-202 Clinical Data at the 2021 ASCO Virtual Annual MeetingBusiness Wire • 04/28/21
Alpine Immune Sciences Presents Clinical and Preclinical Oncology Program Updates at AACR Virtual Annual Meeting IBusiness Wire • 04/12/21
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/19/21
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/18/21
Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial ResultsBusiness Wire • 03/18/21
Alpine Immune Sciences to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate UpdateBusiness Wire • 03/11/21
Alpine Immune Sciences Announces Poster Presentations at AACR Virtual Annual Meeting IBusiness Wire • 03/10/21
Alpine Immune Sciences to Participate in Upcoming Virtual Healthcare ConferencesBusiness Wire • 02/22/21
Alpine Immune Sciences to Present at 39th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 12/17/20
Alpine Immune Sciences to Participate in Fireside Chat at the Evercore ISI 3rd Annual HealthCONx Virtual ConferenceBusiness Wire • 11/24/20
Alpine Immune Sciences to Participate in Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceBusiness Wire • 11/16/20